• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Canary Foundation receives $8.5M to advance cancer early detection studies

Canary Foundation receives $8.5M to advance cancer early detection studies

August 23, 2012
CenterWatch Staff

Canary Foundation, a cancer-focused non-profit based in Palo Alto, Calif., has received two contributions totaling $8.5 million to advance Canary’s goal of developing cancer early detection diagnostic tools.

The first gift, $7.5 million, is from the William K. Bowes Jr. Foundation to support a faculty position focused on clinical trials at the Canary Center at Stanford.  The management of the clinical trial process is a growing need at the center with requirements ranging from the approval process for patient studies, storing and testing samples from current clinical trials and growing the center's ability to support current and future clinical trials. The gift will also provide funds for the Founder's Fund that supports unmet needs and special projects.

The second donation of $1 million is from the Frank and Denise Quattrone Foundation and supports the Prostate Active Surveillance Study (PASS). A clinical trial involving 1,000 men, PASS is looking for ways to distinguish lethal versus non-lethal prostate cancer.  This gift is timely as the prostate cancer science team moves deeper into the trial, providing funds to complete the enrollment of men, gather and test samples and develop important industry partners.

"These contributions create new momentum for our research," said Ronica Smucker, executive director of Canary Foundation. "Moving the studies out of the lab and to patients, with FDA approval, helps prove the efficacy of the blood and imaging tests we are developing that can save lives on a widespread basis. The support of these foundations brings Canary's mission to a whole new level."

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing